"Androstane-3,17-diol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.
| Descriptor ID |
D015113
|
| MeSH Number(s) |
D04.210.500.054.040.080 D06.472.334.851.968.500
|
| Concept/Terms |
Androstane-3,17-diol- Androstane-3,17-diol
- Androstane 3,17 diol
- 5-Androstane-3,17-diol
- 5 Androstane 3,17 diol
|
Below are MeSH descriptors whose meaning is more general than "Androstane-3,17-diol".
Below are MeSH descriptors whose meaning is more specific than "Androstane-3,17-diol".
This graph shows the total number of publications written about "Androstane-3,17-diol" by people in this website by year, and whether "Androstane-3,17-diol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androstane-3,17-diol" by people in Profiles.
-
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes Control. 2016 Feb; 27(2):175-82.
-
Associations of serum sex steroid hormone and 5a-androstane-3a,17?-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1823-32.
-
Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer. Cancer Res. 2011 Feb 15; 71(4):1486-96.
-
5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. J Cell Biochem. 2008 Aug 01; 104(5):1612-24.